A new approach to overcoming antibiotic-resistant bacteria: Traditional Chinese medicine therapy based on the gut microbiota

With the irrational use of antibiotics and the increasing abuse of oral antibiotics, the drug resistance of gastrointestinal pathogens has become a prominent problem in clinical practice. Gut microbiota plays an important role in maintaining human health, and the change of microbiota also affects the activity of pathogenic bacteria. Interfering with antibiotic resistant bacteria by affecting gut microbiota has also become an important regulatory signal. In clinical application, due to the unique advantages of traditional Chinese medicine in sterilization and drug resistance, it is possible for traditional Chinese medicine to improve the gut microbial microenvironment. This review discusses the strategies of traditional Chinese medicine for the treatment of drug-resistant bacterial infections by changing the gut microenvironment, unlocking the interaction between microbiota and drug resistance of pathogenic bacteria.

[1]  M. Bassetti,et al.  Current and emerging drug treatment strategies to tackle invasive community-associated methicillin-resistant Staphylococcus aureus (MRSA) infection: what are the challenges? , 2022, Expert opinion on pharmacotherapy.

[2]  R. Bo,et al.  Bactericidal activity of gallic acid against multi-drug resistance Escherichia coli. , 2022, Microbial pathogenesis.

[3]  Xuming Deng,et al.  A natural compound hyperoside targets Salmonella Typhimurium T3SS needle protein InvG. , 2022, Food & Function.

[4]  Xuezhi Zhang,et al.  Revealing the novel effect of Jinghua Weikang capsule against the antibiotic resistance of Helicobacter pylori , 2022, Frontiers in Microbiology.

[5]  Shuwen Han,et al.  Intestinal phages interact with bacteria and are involved in human diseases , 2022, Gut microbes.

[6]  Qiyun Wu,et al.  The water extract of Aloe vera prevents fluoxetine-induced multiple-drug resistance of E. coli by inhibiting reactive oxygen species formation and membrane permeability. , 2022, Phytomedicine.

[7]  U. Holzgrabe,et al.  Isolation and Characterization of Galloylglucoses Effective against Multidrug-Resistant Strains of Escherichia coli and Klebsiella pneumoniae , 2022, Molecules.

[8]  Xu Jia,et al.  Effects of Traditional Chinese Medicine and its Active Ingredients on Drug-Resistant Bacteria , 2022, Frontiers in Pharmacology.

[9]  Siyuan Lv,et al.  In Vitro Antibacterial Experiments of Qixingjian Decoction and Its Synergistic Interaction with Oxacillin against Clinical Isolates of Methicillin-Resistant Staphylococcus aureus , 2022, Evidence-based complementary and alternative medicine : eCAM.

[10]  Khalid Mehmood,et al.  Methicillin resistant Staphylococcus aureus: A brief review of virulence and resistance , 2022, Journal of the Pakistan Medical Association.

[11]  D. Quach,et al.  Emergence of amoxicillin resistance and identification of novel mutations of the pbp1A gene in Helicobacter pylori in Vietnam , 2021, BMC Microbiology.

[12]  Yun Zhuang,et al.  Identification of the antibacterial mechanism of cryptotanshinone on methicillin-resistant Staphylococcus aureus using bioinformatics analysis , 2021, Scientific Reports.

[13]  O. Kang,et al.  Bisdemethoxycurcumin Reduces Methicillin-Resistant Staphylococcus aureus Expression of Virulence-Related Exoproteins and Inhibits the Biofilm Formation , 2021, Toxins.

[14]  M. Tilahun,et al.  Emerging Carbapenem-Resistant Enterobacteriaceae Infection, Its Epidemiology and Novel Treatment Options: A Review , 2021, Infection and drug resistance.

[15]  Yanzhang Li,et al.  A combination therapy of Phages and Antibiotics: Two is better than one , 2021, International journal of biological sciences.

[16]  Dayong Wu,et al.  Stachyose inhibits vancomycin-resistant Enterococcus colonization and affects gut microbiota in mice. , 2021, Microbial pathogenesis.

[17]  Hisham A. Abbas,et al.  Tackling Virulence of Pseudomonas aeruginosa by the Natural Furanone Sotolon , 2021, Antibiotics.

[18]  Iwona Skiba-Kurek,et al.  Evaluation of Biofilm Formation and Prevalence of Multidrug-Resistant Strains of Staphylococcus epidermidis Isolated from Neonates with Sepsis in Southern Poland , 2021, Pathogens.

[19]  R. L. Pereira,et al.  Effect of Carvacrol and Thymol on NorA efflux pump inhibition in multidrug-resistant (MDR) Staphylococcus aureus strains , 2021, Journal of Bioenergetics and Biomembranes.

[20]  M. Brito,et al.  Drug Resistance and Epigenetic Modulatory Potential of Epigallocatechin-3-Gallate Against Staphylococcus aureus , 2021, Current Microbiology.

[21]  V. Shriram,et al.  Embelin-loaded chitosan gold nanoparticles interact synergistically with ciprofloxacin by inhibiting efflux pumps in multidrug-resistant Pseudomonas aeruginosa and Escherichia coli. , 2021, Environmental research.

[22]  H. Tan,et al.  Inhibitory properties of Chinese Herbal Formula SanHuang decoction on biofilm formation by antibiotic-resistant Staphylococcal strains , 2021, Scientific Reports.

[23]  G. Kerbauy,et al.  Methicillin-Resistant Staphylococcus haemolyticus Displaying Reduced Susceptibility to Vancomycin and High Biofilm-Forming Ability. , 2021, Infectious Diseases - Drug Targets.

[24]  Hong‐Mei Liu,et al.  Ginkgo biloba exocarp extracts inhibit S. aureus and MRSA by disrupting biofilms and affecting gene expression. , 2021, Journal of ethnopharmacology.

[25]  S. Mazzacane,et al.  Bacteriophages as a Potential 360-Degree Pathogen Control Strategy , 2021, Microorganisms.

[26]  Liujiao Bian,et al.  Screening and identification of bioactive components resistant to metallo-beta-lactamase from Schisandra chinensis (Turcz.) Baill. by metalloenzyme-immobilized affinity chromatography. , 2021, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[27]  R. Banerjee,et al.  Combinatorial liposomes of berberine and curcumin inhibit biofilm formation and intracellular methicillin resistant Staphylococcus aureus infections and associated inflammation. , 2021, Journal of materials chemistry. B.

[28]  Y. Qiu,et al.  Novel Opportunity to Reverse Antibiotic Resistance: To Explore Traditional Chinese Medicine With Potential Activity Against Antibiotics-Resistance Bacteria , 2020, Frontiers in Microbiology.

[29]  G. Dantas,et al.  The Gut Microbiome as a Reservoir for Antimicrobial Resistance. , 2020, The Journal of infectious diseases.

[30]  Prija Ponnan,et al.  Inhibition of penicillin-binding protein 2a (PBP2a) in methicillin resistant Staphylococcus aureus (MRSA) by combination of oxacillin and a bioactive compound from Ramalinaroesleri. , 2020, Microbial pathogenesis.

[31]  L. Rice,et al.  Resistance in Vancomycin-Resistant Enterococci. , 2020, Infectious disease clinics of North America.

[32]  Xia Li,et al.  The combined antibacterial effects of sodium new houttuyfonate and berberine chloride against growing and persistent methicillin-resistant and vancomycin-intermediate Staphylococcus aureus , 2020, BMC Microbiology.

[33]  M. Arshad,et al.  The Role of Probiotics, Prebiotics and Synbiotics in Combating Multidrug - Resistant Organisms. , 2020, Clinical therapeutics.

[34]  Tangjuan Liu,et al.  Antibacterial synergy between linezolid and baicalein against methicillin-resistant Staphylococcus aureus biofilm in vivo. , 2020, Microbial pathogenesis.

[35]  S. Gibbons,et al.  Synergism of sophoraflavanone G with norfloxacin against effluxing antibiotic-resistant Staphylococcus aureus. , 2020, International journal of antimicrobial agents.

[36]  Liang Liu,et al.  Contribution of traditional Chinese medicine to the treatment of COVID-19 , 2020, Phytomedicine.

[37]  Z. Jia,et al.  Antibacterial potential of Forsythia suspensa polysaccharide against resistant Enterobacter cloacae with SHV‐12 extended‐spectrum β‐lactamase (ESBL) , 2020, Journal of cellular and molecular medicine.

[38]  Nguyen Dang Khoa Le,et al.  High rates of clarithromycin and levofloxacin resistance of Helicobacter pylori in patients with chronic gastritis in the South East area of Vietnam. , 2020, Journal of global antimicrobial resistance.

[39]  Rui-sheng Li,et al.  Palmatine ameliorates Helicobacter pylori-induced chronic atrophic gastritis by inhibiting MMP-10 through ADAM17/EGFR. , 2020, European journal of pharmacology.

[40]  R. Benjamin,et al.  Methylsulfonylmethane Exhibits Bacteriostatic Inhibition of Vancomycin-Resistant Enterococcus faecium, In Vitro. , 2020, Microbial Drug Resistance.

[41]  R. Karaman,et al.  Resistance of Gram-Positive Bacteria to Current Antibacterial Agents and Overcoming Approaches , 2020, Molecules.

[42]  L. Cowen,et al.  Antifungal Drug Resistance: Molecular Mechanisms in Candida albicans and Beyond. , 2020, Chemical reviews.

[43]  W. van Schaik,et al.  Horizontal transfer of antibiotic resistance genes in the human gut microbiome. , 2020, Current opinion in microbiology.

[44]  D. C. O. Gomes,et al.  Epigallocatechin gallate has antibacterial and antibiofilm activity in methicillin resistant and susceptible Staphylococcus aureus of different lineages in non-cytotoxic concentrations , 2019, Natural product research.

[45]  A. Sundsfjord,et al.  The efficacy of mecillinam against clinical multidrug-resistant Escherichia coli in a murine urinary tract infection model. , 2019, International journal of antimicrobial agents.

[46]  Asad U. Khan,et al.  Synergistic fungicidal activity with low doses of eugenol and amphotericin B against Candida albicans. , 2019, Biochemical and biophysical research communications.

[47]  Hailong Li,et al.  Antibacterial activity of a novel Forsythia suspensa fruit mediated green silver nanoparticles against food-borne pathogens and mechanisms investigation. , 2019, Materials science & engineering. C, Materials for biological applications.

[48]  A. Oliver,et al.  Epidemiology and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Infections , 2019, Clinical Microbiology Reviews.

[49]  S. Bonhoeffer,et al.  Salmonella persisters promote the spread of antibiotic resistance plasmids in the gut , 2019, Nature.

[50]  Jianzhong Shen,et al.  Natural flavones from Morus alba against MRSA via targeting the proton motive force and membrane permeability. , 2019, Journal of agricultural and food chemistry.

[51]  Chung-Yi Wang,et al.  Antimicrobial Effects and Mechanisms of Ethanol Extracts of Psoralea corylifolia Seeds Against Listeria monocytogenes and Methicillin-Resistant Staphylococcus aureus. , 2019, Foodborne pathogens and disease.

[52]  S. Skariyachan,et al.  Recent perspectives on the virulent factors and treatment options for multidrug-resistant Acinetobacter baumannii , 2019, Critical reviews in microbiology.

[53]  M. Vestergaard,et al.  Antibiotic Resistance and the MRSA Problem , 2019, Microbiology spectrum.

[54]  H. Horz,et al.  Fighting Pathogenic Bacteria on Two Fronts: Phages and Antibiotics as Combined Strategy , 2019, Front. Cell. Infect. Microbiol..

[55]  Guojun Wu,et al.  Antibacterial activity and mechanism of silver nanoparticles against multidrug-resistant Pseudomonas aeruginosa , 2019, International journal of nanomedicine.

[56]  P. Turner,et al.  Phage Therapy: A Renewed Approach to Combat Antibiotic-Resistant Bacteria. , 2019, Cell host & microbe.

[57]  Y. Briers,et al.  The Preclinical and Clinical Progress of Bacteriophages and Their Lytic Enzymes: The Parts are Easier than the Whole , 2019, Viruses.

[58]  S. K. Pandian,et al.  In vitro and in vivo biofilm inhibitory efficacy of geraniol-cefotaxime combination against Staphylococcus spp. , 2019, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[59]  Q. Mu,et al.  Isovalerylshikonin, a new resistance-modifying agent from Arnebia euchroma, supresses antimicrobial resistance of drug-resistant Staphylococcus aureus. , 2019, International journal of antimicrobial agents.

[60]  D. Feola,et al.  Effect of increasing meropenem MIC on the killing activity of meropenem in combination with amikacin or polymyxin B against MBL- and KPC-producing Enterobacter cloacae. , 2018, Diagnostic microbiology and infectious disease.

[61]  P. Nordmann,et al.  Antimicrobial Resistance in Escherichia coli , 2018, Microbiology spectrum.

[62]  E. Snitkin,et al.  Identification of Pathogenicity-Associated Loci in Klebsiella pneumoniae from Hospitalized Patients , 2018, mSystems.

[63]  R. Atun,et al.  Estimating the burden of antimicrobial resistance: a systematic literature review , 2018, Antimicrobial Resistance & Infection Control.

[64]  Hualiang Jiang,et al.  The Mechanism by Which Luteolin Disrupts the Cytoplasmic Membrane of Methicillin-Resistant Staphylococcus aureus. , 2018, The journal of physical chemistry. B.

[65]  Joon-Hee Lee,et al.  Antibiofilm agents: A new perspective for antimicrobial strategy , 2017, Journal of Microbiology.

[66]  Daqiang Wu,et al.  Mechanism of berberine-mediated fluconazole-susceptibility enhancement in clinical fluconazole-resistant Candida tropicalis isolates. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[67]  Z. Zeng,et al.  Fifth Chinese National Consensus Report on the management of Helicobacter pylori infection , 2017, Helicobacter.

[68]  C. O'Morain,et al.  Population screening and treatment of Helicobacter pylori infection , 2017, Nature Reviews Gastroenterology &Hepatology.

[69]  Jung Hun Lee,et al.  Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options , 2017, Front. Cell. Infect. Microbiol..

[70]  Ekambaram Perumal,et al.  Metal oxide nanoparticles as antimicrobial agents: a promise for the future. , 2017, International journal of antimicrobial agents.

[71]  P. Fong,et al.  Synergistic antibacterial effects of herbal extracts and antibiotics on methicillin-resistant Staphylococcus aureus: A computational and experimental study , 2017, Experimental biology and medicine.

[72]  Y. Shamoo,et al.  Differential Penicillin-Binding Protein 5 (PBP5) Levels in the Enterococcus faecium Clades with Different Levels of Ampicillin Resistance , 2016, Antimicrobial Agents and Chemotherapy.

[73]  M. Rybak,et al.  β-Lactamase Inhibitors Enhance the Synergy between β-Lactam Antibiotics and Daptomycin against Methicillin-Resistant Staphylococcus aureus , 2016, Antimicrobial Agents and Chemotherapy.

[74]  V. Sperandio,et al.  Interactions between the microbiota and pathogenic bacteria in the gut , 2016, Nature.

[75]  O. Kang,et al.  Luteolin potentiates the effects of aminoglycoside and β-lactam antibiotics against methicillin-resistant Staphylococcus aureus in vitro. , 2016, Experimental and therapeutic medicine.

[76]  A. Lyra,et al.  Probiotic approach to prevent antibiotic resistance , 2016, Annals of medicine.

[77]  T. van der Poll,et al.  The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia , 2015, Gut.

[78]  Yang Wang,et al.  Synergy between baicalein and penicillins against penicillinase-producing Staphylococcus aureus. , 2015, International journal of medical microbiology : IJMM.

[79]  A. Dziedzic,et al.  Inhibition of Oral Streptococci Growth Induced by the Complementary Action of Berberine Chloride and Antibacterial Compounds , 2015, Molecules.

[80]  C. Crank,et al.  Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management , 2015, Infection and Drug Resistance.

[81]  Xiao-qiang Mo,et al.  Inhibitory effects of emodin, baicalin, schizandrin and berberine on hefA gene: treatment of Helicobacter pylori-induced multidrug resistance. , 2015, World journal of gastroenterology.

[82]  G. Im,et al.  Eugenol: A Phyto-Compound Effective against Methicillin-Resistant and Methicillin-Sensitive Staphylococcus aureus Clinical Strain Biofilms , 2015, PloS one.

[83]  K. Fung,et al.  Combating against methicillin‐resistant Staphylococcus aureus – two fatty acids from Purslane (Portulaca oleracea L.) exhibit synergistic effects with erythromycin , 2015, The Journal of pharmacy and pharmacology.

[84]  C. Brearley,et al.  Cephalosporinases associated with outer membrane vesicles released by Bacteroides spp. protect gut pathogens and commensals against β-lactam antibiotics , 2014, The Journal of antimicrobial chemotherapy.

[85]  D. Dominey-Howes,et al.  The Antimicrobial Resistance Crisis: Causes, Consequences, and Management , 2014, Front. Public Health.

[86]  T. Řezanka,et al.  Pseudomonas biofilms: possibilities of their control. , 2014, FEMS microbiology ecology.

[87]  Calvin Yu-Chian Chen,et al.  The Inhibition of Folylpolyglutamate Synthetase (folC) in the Prevention of Drug Resistance in Mycobacterium tuberculosis by Traditional Chinese Medicine , 2014, BioMed research international.

[88]  R. Durairaj,et al.  Antibiofilm properties of chemically synthesized silver nanoparticles found against Pseudomonas aeruginosa , 2014, Journal of Nanobiotechnology.

[89]  Daniel N. Wilson Ribosome-targeting antibiotics and mechanisms of bacterial resistance , 2013, Nature Reviews Microbiology.

[90]  G. Weinstock,et al.  Daptomycin-Resistant Enterococcus faecalis Diverts the Antibiotic Molecule from the Division Septum and Remodels Cell Membrane Phospholipids , 2013, mBio.

[91]  C. Soumet,et al.  Resistance in Escherichia coli: variable contribution of efflux pumps with respect to different fluoroquinolones , 2013, Journal of applied microbiology.

[92]  S. Rice,et al.  Bis-(3′-5′)-Cyclic Dimeric GMP Regulates Antimicrobial Peptide Resistance in Pseudomonas aeruginosa , 2013, Antimicrobial Agents and Chemotherapy.

[93]  F. Hamadi,et al.  A study of pH effects on the bacterial surface physicochemical properties of Acinetobacter baumannii. , 2013, Colloids and surfaces. B, Biointerfaces.

[94]  C. Finch,et al.  Vancomycin-resistant Enterococcus bacteremia: an evaluation of treatment with linezolid or daptomycin. , 2012, Journal of hospital medicine.

[95]  A. MacGowan,et al.  The role of pharmacokinetics/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approach. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[96]  Qing Peng,et al.  Baicalein Suppresses the SOS Response System of Staphylococcus Aureus Induced by Ciprofloxacin , 2011, Cellular Physiology and Biochemistry.

[97]  A. Viale,et al.  Profound Alterations of Intestinal Microbiota following a Single Dose of Clindamycin Results in Sustained Susceptibility to Clostridium difficile-Induced Colitis , 2011, Infection and Immunity.

[98]  Ying Xiong,et al.  Antibacterial and anti-inflammatory effects of extracts and fractions from Polygonum capitatum. , 2011, Journal of ethnopharmacology.

[99]  S. Dunca,et al.  Erratum to: Enhanced antibacterial effect of silver nanoparticles obtained by electrochemical synthesis in poly(amide-hydroxyurethane) media , 2011, Journal of materials science. Materials in medicine.

[100]  P. Courvalin,et al.  Efflux-Mediated Antibiotic Resistance in Acinetobacter spp , 2010, Antimicrobial Agents and Chemotherapy.

[101]  H. Nikaido,et al.  Efflux-Mediated Drug Resistance in Bacteria , 2009, Drugs.

[102]  Regine Hengge,et al.  Principles of c-di-GMP signalling in bacteria , 2009, Nature Reviews Microbiology.

[103]  Dong Hu,et al.  [Study of Scutellaria baicalensis and Baicalin against antimicrobial susceptibility of Helicobacter pylori strains in vitro]. , 2008, Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials.

[104]  Nastassja A. Lewinski,et al.  Cytotoxicity of nanoparticles. , 2008, Small.

[105]  Chong-Zhi Wang,et al.  Scutellaria baicalensis and a constituent flavonoid, baicalein, attenuate ritonavir‐induced gastrointestinal side‐effects , 2007, The Journal of pharmacy and pharmacology.

[106]  M. Deshpande,et al.  Dual Targeting of DNA Gyrase and Topoisomerase IV: Target Interactions of Heteroaryl Isothiazolones in Staphylococcus aureus , 2007, Antimicrobial Agents and Chemotherapy.

[107]  Thomas Bjarnsholt,et al.  Garlic blocks quorum sensing and promotes rapid clearing of pulmonary Pseudomonas aeruginosa infections. , 2005, Microbiology.

[108]  T. Tsuchiya,et al.  Remarkable Synergies between Baicalein and Tetracycline, and Baicalein and β‐Lactams against Methicillin‐Resistant Staphylococcus aureus , 2005, Microbiology and immunology.

[109]  T. Vernet,et al.  Biochemical Characterization of Streptococcus pneumoniae Penicillin-Binding Protein 2b and Its Implication in β-Lactam Resistance , 2004, Antimicrobial Agents and Chemotherapy.

[110]  Stephan Harbarth,et al.  Antibiotic Selection Pressure and Resistance in Streptococcus pneumoniae and Streptococcus pyogenes , 2004, Emerging infectious diseases.

[111]  D. Davies,et al.  Understanding biofilm resistance to antibacterial agents , 2003, Nature Reviews Drug Discovery.

[112]  J. McClure,et al.  Transcriptional modulation of bacterial gene expression by subinhibitory concentrations of antibiotics , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[113]  F. Baquero,et al.  Mutation Frequencies and Antibiotic Resistance , 2000, Antimicrobial Agents and Chemotherapy.

[114]  A. Tomasz,et al.  Low-affinity penicillin-binding protein associated with beta-lactam resistance in Staphylococcus aureus , 1984, Journal of bacteriology.

[115]  J. Munita,et al.  Mechanisms of Antibiotic Resistance , 2016, Microbiology spectrum.

[116]  R. Gryko,et al.  Bacteriophages as an alternative strategy for fighting biofilm development. , 2014, Polish journal of microbiology.

[117]  Duan Ya CHINET 2009 surveillance of bacterial resistance in China , 2010 .

[118]  Y. Jun,et al.  Pharmacodynamic Effect of Compound Qingre Granules on Acute Drug-resistance Bacterial Infection , 2009 .

[119]  H. Krisch,et al.  [The discovery of a natural phenomenon, "Phage-Antibiotic Synergy". Implications for phage therapy]. , 2008, Medecine sciences : M/S.